Astrana Health Future Growth

Future criteria checks 2/6

Astrana Health is forecast to grow earnings and revenue by 18.7% and 16% per annum respectively while EPS is expected to grow by 17.1% per annum.

Key information

18.7%

Earnings growth rate

17.1%

EPS growth rate

Healthcare earnings growth20.6%
Revenue growth rate16.0%
Future return on equityn/a
Analyst coverage

Good

Last updated05 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:3AM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,71797N/A1474
12/31/20252,26780841068
12/31/20241,8226356828
6/30/20241,592685064N/A
3/31/20241,454625266N/A
12/31/20231,387614068N/A
9/30/20231,32845112134N/A
6/30/20231,297466183N/A
3/31/20231,218454666N/A
12/31/20221,144455982N/A
9/30/20221,04558-40-15N/A
6/30/2022955694172N/A
3/31/2022861704884N/A
12/31/2021774695170N/A
9/30/2021756706380N/A
6/30/2021709535765N/A
3/31/2021698476465N/A
12/31/2020687384546N/A
9/30/2020689355252N/A
6/30/2020665224748N/A
3/31/20206301878N/A
12/31/2019561141314N/A
9/30/2019488434N/A
6/30/201949910-11-10N/A
3/31/201949291617N/A
12/31/2018520112425N/A
9/30/2018506284647N/A
6/30/2018436243941N/A
3/31/201839524N/A35N/A
12/31/201735626N/A52N/A
9/30/201733613N/A44N/A
6/30/201732311N/A45N/A
3/31/201731712N/A47N/A
12/31/201630611N/A22N/A
12/31/201531313N/A32N/A
12/31/2014134-1N/A16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 3AM's forecast earnings growth (18.7% per year) is above the savings rate (0.8%).

Earnings vs Market: 3AM's earnings (18.7% per year) are forecast to grow slower than the German market (20% per year).

High Growth Earnings: 3AM's earnings are forecast to grow, but not significantly.

Revenue vs Market: 3AM's revenue (16% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: 3AM's revenue (16% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 3AM's Return on Equity is forecast to be high in 3 years time


Discover growth companies